Healthtech

Health-tech startup MedAdvisor is looking to raise $45 million as it buys a US medication venture for $49 million

- November 2, 2020 2 MIN READ

Shares in ASX-listed MedAdvisor have been placed in a trading halt today with the health-tech venture announcing plans to acquire US-based medication adherence company Adheris for US$34.5 million (AU$49m), while also raising AU$45 million to fund the acquisition. The company’s seeking a minimum of AU$35m in funds through an institutional placement at $0.45 per share,… Read more »